Long-Term Stroke and Mortality Risk Reduction Associated With Acute-Phase Paxlovid Use in Mild-to-Moderate COVID-19. Chuang CH, Wang YH, Yeh LT, Yeh CB, et al. J Med Virol 2025;97:e70351.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chuang CH, Wang YH, Yeh LT, Yeh CB, et al. Long-Term Stroke and Mortality Risk Reduction Associated With Acute-Phase Paxlovid Use in Mild-to-Moderate COVID-19. J Med Virol 2025;97:e70351.
PMID: 40223754